Prevalence and Impact of Diarrhea on Health-related Quality of Life in HIV-infected Patients in the Era of Highly Active Antiretroviral Therapy
Authors:
- Uzma SiddiquiUSUzma Siddiqui
- Edmund J. BiniEBEdmund J. Bini
- Khushbu ChandaranaKCKhushbu Chandarana
- Jennifer LeongJLJennifer Leong
- Sabena RamsettySRSabena Ramsetty
- Danise SchiliroDSDanise Schiliro
- Michael PolesMPMichael Poles
- 1 May 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Clinical Gastroenterology
- Vol. 41 (5) , 484-490
Abstract
Before the introduction of highly active antiretroviral therapy (HAART), the majority of HIV-infected patients experienced diarrhea. The aims of this study were to compare the prevalence of diarrhea among HIV-infected and uninfected patients in the HAART era, and to evaluate the impact of diarrhea on health-related quality of life (HRQOL). Diarrheal symptoms experienced by 163 consecutive HIV-infected patients and 253 HIV-seronegative control subjects were ascertained using a validated questionnaire. The HRQOL of these patients was assessed using the Medical Outcomes Study (MOS) SF-36 and MOS-HIV Health surveys. Among the 163 HIV-infected patients, the median CD4 cell count was 370 cells/mm3 and 150 individuals were taking HAART. Significantly, more HIV-infected subjects reported having 3 or more bowel movements daily within the past 7 days than did HIV-seronegative subjects (28.2% vs. 7.1%, P<0.001), even after adjusting for potential confounding variables (odds ratios=6.65; 95% confidence intervals, 3.36-13.17). In addition, diarrhea was significantly more common in HIV-infected patients than in control subjects when assessed by several other criteria. HIV-infected patients reported significantly worse HRQOL across all domains of the MOS SF-36 as compared with control subjects. Among HIV-infected patients, individuals with diarrhea had significantly worse HRQOL in nearly all domains of the MOS-HIV as compared with those without diarrhea. Diarrhea remains an important clinical problem in HIV-infected patients and is associated with significant impairments in HRQOL. It is important that healthcare providers specifically evaluate their HIV-infected patients for diarrhea so that these symptoms may be optimally managed.Keywords
This publication has 28 references indexed in Scilit:
- Prevalence of diarrhoea in the community in Australia, Canada, Ireland, and the United StatesInternational Journal of Epidemiology, 2005
- Differences in Symptom Expression in Older HIV-Positive PatientsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2003
- AGA Technical Review on the Evaluation and Management of Chronic Diarrhea☆Gastroenterology, 1999
- Diarrhea and AIDS in the Era of Highly Active Antiretroviral TherapyClinical Infectious Diseases, 1999
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998
- Diarrhea and quality of life in ambulatory HIV-infected patientsDigestive Diseases and Sciences, 1996
- The prevalence and aetiology of persistent diarrhoea in adults in urban ZambiaActa Tropica, 1996
- Gastrointestinal symptoms in ambulatory HIV-infected patientsDigestive Diseases and Sciences, 1993
- A Health Status Questionnaire Using 30 Items From The Medical Outcomes StudyMedical Care, 1991
- Intestinal infections in patients with acquired immunodeficiency syndromeDigestive Diseases and Sciences, 1989